EUROPEAN JOURNAL OF CLINICAL INVESTIGATION（欧洲临床研究杂志）影响因子_期刊投稿发表

期刊简介

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI考虑了从最复杂的基础分子科学到应用临床和转化研究和循证医学的广泛的子专业范围内的任何原始贡献。EJCI发表有关人类生物学和疾病的遗传、分子、细胞或生理学基础的高质量研究报告，以及涉及疾病的流行、诊断、病程、治疗和预防的研究。我们主要对与人类直接相关的研究感兴趣，但也鼓励提交稳健的体外和动物研究。该杂志对采用创新方法和实验室、临床和流行病学方法和技术相结合的跨学科工作和研究非常感兴趣。考虑了几类手稿（详细描述见下文）：社论、原创文章（也包括随机临床试验、系统性综述和荟萃分析）、综述（叙述性综述）、观点文章（包括辩论、观点和评论）;和给编辑的信。

《EUROPEAN JOURNAL OF CLINICAL INVESTIGATION》期刊已被查看：次

分区信息